SCHEMBL2330298

SCHEMBL2330298

O=c1nc(-c2ccc(-c3c(C(F)(F)F)oc4cc(O)ccc4c3=O)c(F)c2)[nH]o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 8/20 0.58
▸ ESR2 Q92731 4/20 0.58
▸ PSD A5PKW4 1/20 0.53
▸ LMNA P02545 2/20 0.43
▸ TTR P02766 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ HPGD P15428 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ TP53 P04637 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ CASP1 P29466 2/20 0.38
▸ CASP7 P55210 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2334911 0.90 ESR1 (0.61) ESR1ESR2PSDLMNATTR
SCHEMBL2330302 0.83 ESR1 (0.58) ESR1ESR2PSDLMNATTR
SCHEMBL2333818 0.76 ESR1 (0.61) ESR1ESR2PSDLMNATTR
SCHEMBL2328638 0.75 ESR1 (0.60) ESR1ESR2PSDLMNATTR
SCHEMBL3957035 0.74 ESR1 (1.00) ESR1ESR2PSDLMNATTR
SCHEMBL2182106 0.74 ESR1 (0.90) ESR1ESR2PSDLMNATTR
SCHEMBL2361378 0.73 ESR1 (0.61) ESR1ESR2PSDLMNATTR
SCHEMBL2329191 0.73 ESR1 (0.61) ESR1ESR2PSDLMNATTR
SCHEMBL2329046 0.73 ESR1 (0.58) ESR1ESR2PSDLMNATTR
SCHEMBL2332579 0.72 ESR1 (0.71) ESR1ESR2PSDLMNATTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2533638-A1 NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS N30 Pharmaceuticals, Inc. (US) 2012-12-19 — — EP disclosed
WO-2011100433-A1 NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS N30 PHARMACEUTICALS, LLC (US) 2011-08-18 — — WO disclosed
Send feedback